We are live on
!
Find out more
MG
Meditor Group Portfolio holdings
AUM
$48.1M
1-Year Est. Return
38.67%
This Fund
S&P 500
This Quarter
Est. Return
+11.11%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$356M
AUM Growth
-$3.37M
(-0.94%)
Cap. Flow
-$42.2M
Cap. Flow
% of AUM
-11.85%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelixis
EXEL
|
+$30.1M |
| 2 |
Alkermes
ALKS
|
+$12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 92.67% |
Similar funds
BHCM
VMV
BHH
LAMC
MAM
BCM
LOF
CLCM
Meditor Group's Q1 2021 Portfolio in Review
As of Q1 2021, Meditor Group held 5 positions worth $356M, down 0.94% from $359M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Meditor Group withdrew a net $42.2M in Q1 2021, closing 1 position and reducing 1 holding. Its most notable exit was Alkermes, an estimated $12M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 93% a quarter earlier.
- Meditor Group's biggest Q1 2021 reduction was Exelixis, cutting an estimated $30.1M.
- Meditor Group fully exited Alkermes in Q1 2021, selling an estimated $12M.
- Meditor Group's ten largest holdings make up 100% of its $356M portfolio in Q1 2021.
- Meditor Group opened 0 new positions and closed 1 in Q1 2021.
- Meditor Group's portfolio value fell 0.94% quarter-over-quarter to $356M.
Based on Meditor Group's 13F filing for Q1 2021, filed 9 Apr 2021.